Matt Havens
Medical · Bolivar, MONPI 1992912216
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 188 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 26.7% of the total.
Across 188 payments — averaging $17.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$873
- Abbott$339
- Novo Nordisk$324
- Pfizer$318
- Lilly USA, LLC$180
- E.r. Squibb & Sons, L.L.C.$164
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,266100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $873 |
| Abbott | 16 | $339 |
| Novo Nordisk | 19 | $324 |
| Pfizer | 22 | $318 |
| Lilly USA, LLC | 11 | $180 |
| E.r. Squibb & Sons, L.L.C. | 9 | $164 |
| AstraZeneca | 11 | $162 |
| GSK | 10 | $157 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $111 |
| Otsuka America Pharmaceutical, Inc. | 6 | $105 |
| Amgen | 6 | $94 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $65 |
| Dexcom, Inc. | 4 | $62 |
| Eisai Inc. | 3 | $59 |
| Exact Sciences | 3 | $57 |
| Biohaven Pharmaceuticals, Inc. | 3 | $40 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $27 |
| Indivior Inc. | 1 | $27 |
| Organon | 2 | $25 |
| Vertex | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Novartis | 1 | $14 |
| Bayer | 1 | $13 |
How this compares
$3,266 in reported general payments places this provider in the 80th percentile of 198 medical providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 86 | $91,877 |
| EliquisApixaban | 57 | $52,678 |
| MounjaroTirzepatide | 46 | $51,518 |
| JardianceEmpagliflozin | 43 | $50,579 |
| TrulicityDulaglutide | 37 | $41,162 |
| XareltoRivaroxaban | 27 | $38,348 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 72 | $38,219 |
| Nurtec OdtRimegepant Sulfate | 22 | $36,383 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 44 | $29,565 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 33 | $25,190 |
| LinzessLinaclotide | 28 | $17,778 |
| Spiriva HandihalerTiotropium Bromide | 14 | $15,802 |
| FarxigaDapagliflozin Propanediol | 14 | $12,548 |
| Advair HfaFluticasone Propion/Salmeterol | 23 | $9,753 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $8,242 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $180 | $92,67983 claims |
| Novo NordiskOzempic | $324 | $91,87786 claims |
| PfizerEliquis, Nurtec Odt | $318 | $89,06179 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $162 | $42,11358 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Arexvy | $157 | $37,19264 claims |
| AbbVieLinzess | $873 | $17,77828 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 198 medical providers in Missouri.
Other medical in Bolivar
- Melanie ChisamSpringfield$92K
- Emily JensenBowling Green$51K
- Sarah WilmsmeyerChesterfield$22K
- Amy MosmanSaint Louis$21K
- Dustin BartlettSpringfield$21K
- Alexa Fider-WhyteSaint Louis$18K
- Megan Isaacson-SchmidSaint Louis$16K
- Erin YoffieSaint Louis$16K
- Corey WhitesidesColumbia$15K
- David WinchellSaint Peters$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.